Mainstream

Halozyme Projects $1.15b $1.225b Revenue For 2025 With Growth From Key Products

Halozyme projects $1.15B-$1.225B revenue for 2025 with growth from key products

Halozyme projects $1.15B-$1.225B revenue for 2025 with growth from key products

Post ContenthaloRead More

You might also be interested in reading HCM III Acquisition announces pricing of $220M IPO.

February 19, 2025
In Mainstream